p53 polymorphisms and haplotypes in breast cancer

Area of Science:

• Genetics
• Oncology
• Molecular Biology

Background:

• The p53 tumor suppressor gene plays a critical role in preventing cancer.
• Genetic variations, or polymorphisms, in p53 may influence breast cancer risk.
• Understanding these variations is key to personalized cancer prevention and treatment.

Purpose of the Study:

• To investigate the association between specific p53 gene polymorphisms and breast cancer.
• To analyze the role of p53 haplotypes in breast cancer development and differentiation.
• To identify potential genetic markers for breast cancer risk and malignancy.

Main Methods:

• Genotyping of three p53 polymorphisms: BstUI (exon 4), MspI (intron 6), and a 16 bp duplication (intron 3).
• Analysis of p53 haplotype combinations in breast cancer patients and healthy controls.
• Statistical analysis to determine allele and genotype frequencies and their association with breast cancer.

Main Results:

• A significant increase in the BstUI A1 (pro) allele frequency was observed in breast cancer patients (P = 0.016).
• Individuals carrying the pro allele showed a higher risk of breast cancer (OR, 1.47; P = 0.014).
• Specific p53 haplotype combinations (BstUI-16 bp-MspI) were significantly overrepresented in breast cancer patients.

Conclusions:

• The codon 72 pro allele of the p53 gene may be functionally involved in breast cancer, particularly in less malignant forms.
• Specific p53 haplotype combinations are associated with an increased risk of breast cancer.
• These findings highlight the potential of p53 polymorphisms as biomarkers for breast cancer risk assessment.